Douglas Kerr Insider Trades & Stock Holdings

Chief Medical Officer · Dyne Therapeutics, Inc. · Latest filing Jun 16, 2026

Douglas Kerr, Chief Medical Officer at Dyne Therapeutics, Inc. has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($16.26K), net -$16.26K. Latest filing: disposed of 887 shares of $DYN on Jun 16, 2026 at $18.33.

Trades on file

1

Open-market bought

$0

Open-market sold

$16.26K

Net open-market

-$16.26K

Latest filing

Jun 16, 2026

All insider trades by Douglas Kerr

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$DYN	Sell (Open-market sale) 10b5-1	887	$18.33	$16.26K			+12.1%	+25.7%		Chief Medical Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Douglas Kerr traded

• $DYN

Frequently asked questions

Has Douglas Kerr been buying or selling stock?

Douglas Kerr has 0 open-market purchases and 1 open-market sale on file, net -$16.26K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Douglas Kerr's latest insider trade?

disposed of 887 shares of $DYN on Jun 16, 2026 at $18.33.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.